MedTrace Logo

The Role of MSC in the Treatment of Fistulas in Patients With Perianal Crohn's Disease

NCT03056664 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-02-17

No results posted yet for this study

Summary

Here investigators will carry out this phase II clinical trial to explore a effective therapeutic regimen of MSC in the Crohn's perianal fistula.

Conditions

Interventions

PROCEDURE

Routine drainage surgery

BIOLOGICAL

MSC injection 01

Local MSC injection in peri-anal with a dose of 3×10E6/kg

BIOLOGICAL

MSC injection 02

Local MSC injection in peri-anal with a dose of 6×10E6/kg

OTHER

placebo

NS injection instead of MSC

Sponsors & Collaborators

  • Sixth Affiliated Hospital, Sun Yat-sen University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-12-31
Completion
2019-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03056664 on ClinicalTrials.gov